B & B Pharmaceuticals, Inc.

Warning LetterOpen

United StatesFEI 3000719772Issued Jun 4, 2019

View FDA's record for FEI 3000719772

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3000719772.

Violations0

Issue DateJun 4, 2019

Product TypeDrugs

StatusOpen

Letter Details

Firm: B & B Pharmaceuticals, Inc.
Location: United States
FEI Number: 3000719772
Country: United States
Issue Date: June 04, 2019
Issuing Office: N/A
Product Type: Drugs
Status: Open

Summary

B & B Pharmaceuticals, Inc. received an FDA Warning Letter on June 4, 2019, regarding drug manufacturing or marketing practices. While the specific violations are not detailed in the available metadata, the warning letter indicates regulatory concerns significant enough to warrant formal FDA enforcement action. The warning was issued under FDA's drug regulatory authority, though the specific issuing office and exact violation count are not documented in this summary. This summary is based on limited metadata and does not reflect the complete details contained in the full warning letter.

B & B Pharmaceuticals, Inc. FDA Warning Letter, June 4, 2019